Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 34Rectal Neoplasms 22Triple Negative Breast Neoplasms 16Stomach Neoplasms 16Colorectal Neoplasms 13Neoplasm Metastasis 9Adenocarcinoma 9Pancreatic Neoplasms 8Esophageal Neoplasms 8Adenocarcinoma Of Esophagus 7Neoplasms 5Nasopharyngeal Carcinoma 5Biliary Tract Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Carcinoma, Non-Small-Cell Lung 4Esophageal Squamous Cell Carcinoma 3Colonic Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Spinocerebellar Degenerations 2Ovarian Neoplasms 2Neoplasm, Residual 2Carcinoma 2Anus Neoplasms 2Advanced Solid Tumour 2Somatostatinoma 1Solid Tumors 1Resectable Colon Cancer 1Rectal Cancer Patients 1Peritoneal Neoplasms 1Pathologic Complete Response 1

Interventions

fludarabine 4Cyclophosphamide 4fludarabine phosphate 3Melphalan 3pembrolizumab 2obinutuzumab 2blinatumomab 2Rituximab 2Radiotherapy 2Lenalidomide 2Capecitabine 2Blood Specimen Collection 2trastuzumab deruxtecan 1tislelizumab 1tisagenlecleucel 1thymoglobulin 1tetrathiomolybdate 1talquetamab 1sacituzumab govitecan 1palbociclib 1nilotinib 1isatuximab 1avelumab 1atezolizumab 1acalabrutinib 1Whole-Body Irradiation 1Trastuzumab 1Sirolimus 1Neoadjuvant Therapy 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasm, Residual × Capecitabine × 90 days × Clear all
NCT06134375 2026-04-20

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

Dartmouth-Hitchcock Medical Center

Phase 1/2 Recruiting
204 enrolled
Breast

Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT04768426 2026-04-13

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

Stanford University

Phase 2 Recruiting
40 enrolled
Breast

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡